Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | DDR1 | Q08345 | 3/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | EGLN2 | Q96KS0 | 5/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 0.33 |
| ▸ | PTGES | O14684 | 4/20 | 0.33 |
| ▸ | F3 | P13726 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3034619 | 0.95 | CYP3A4 (0.48) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| Trifluoroacetic Acid SCHEMBL3028598 | 0.93 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| Trifluoroacetic Acid SCHEMBL3034611 | 0.92 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| Trifluoroacetic Acid SCHEMBL3638789 | 0.91 | CYP3A4 (0.47) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| Trifluoroacetic Acid SCHEMBL13560638 | 0.90 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| Trifluoroacetic Acid SCHEMBL3027809 | 0.90 | CYP3A4 (0.41) | CYP3A4CYP2C9CYP2C19KCNH2EPHX2 | |
| SCHEMBL3025466 | 0.90 | CYP3A4 (0.41) | CYP3A4CYP2C9CYP2C19DDR1EPHX2 | |
| Trifluoroacetic Acid SCHEMBL3022995 | 0.90 | CYP3A4 (0.44) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| SCHEMBL3036705 | 0.89 | CYP3A4 (0.47) | CYP3A4CYP2C9CYP2C19KCNH2DDR1 | |
| Trifluoroacetic Acid SCHEMBL3028652 | 0.89 | CYP3A4 (0.46) | CYP3A4CYP2C9CYP2C19KCNH2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304419-B2 | Chemical compounds | GLAXOSMITHKLINE LLC (US) | 2012-11-06 | — | — | US | disclosed |
| US-20100216746-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216746-A1 | CHEMICAL COMPOUNDS | SAMHD1, POLRMT, NUDT1 | CYP3A4 169/4885CYP2C9 720/4885CYP2C19 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.